MedTrace Logo

Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project

NCT03177590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2018-07-31

No results posted yet for this study

Summary

The purpose of the JEMImE project is to create a serious game to help children with Autism and Pervasive Developmental Disorder (PDD) develop facial and vocal emotions in context.

The objective of this study is to record facial and vocal emotional productions in children with autism and PDD in order to create an algorithm for the recognition of facial emotional expressions implemented in the serious game JEMImE.

Conditions

  • Autism
  • Pervasive Developmental Disorder

Interventions

OTHER

Recordings of facial and vocal emotional productions

Children are asked to perform three tasks: 1. an emotional production on imitation (the child with autism or TED will imitate the emotion expressed by an animated avatar) 2. an emotional production by mime of the emotion on command (oral and written) without visualizing the model of imitation 3. Emotional production in context: the child with autism or EFD will describe images forming the story of Frog and as it is read, will produce the appropriate facial and vocal emotions in the context.

Sponsors & Collaborators

  • Fondation Lenval

    lead OTHER

Principal Investigators

  • Sylvie SERRET, MD · Fondation Lenval Hôpitaux Pédiatriques de Nice CHU-LENVAL

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-10
Primary Completion
2017-07-10
Completion
2017-07-10

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03177590 on ClinicalTrials.gov